ES530590A0 - Un procedimiento para la preparacion de antagonistas de los receptores h-2 de la histamina. - Google Patents
Un procedimiento para la preparacion de antagonistas de los receptores h-2 de la histamina.Info
- Publication number
- ES530590A0 ES530590A0 ES530590A ES530590A ES530590A0 ES 530590 A0 ES530590 A0 ES 530590A0 ES 530590 A ES530590 A ES 530590A ES 530590 A ES530590 A ES 530590A ES 530590 A0 ES530590 A0 ES 530590A0
- Authority
- ES
- Spain
- Prior art keywords
- histamine
- procedure
- preparation
- receptors antagonists
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000003710 Histamine H2 Receptors Human genes 0.000 title 1
- 108090000050 Histamine H2 Receptors Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/475,985 US4440933A (en) | 1983-03-16 | 1983-03-16 | Process for preparing 1,2,5-thiadiazoles |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8602721A1 ES8602721A1 (es) | 1985-12-01 |
ES530590A0 true ES530590A0 (es) | 1985-12-01 |
Family
ID=23890020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES530590A Granted ES530590A0 (es) | 1983-03-16 | 1984-03-14 | Un procedimiento para la preparacion de antagonistas de los receptores h-2 de la histamina. |
Country Status (14)
Country | Link |
---|---|
US (1) | US4440933A (es) |
KR (1) | KR860002036B1 (es) |
CA (1) | CA1207763A (es) |
CS (1) | CS241072B2 (es) |
DD (1) | DD218364A5 (es) |
DK (1) | DK155984A (es) |
ES (1) | ES530590A0 (es) |
FI (1) | FI79848C (es) |
GR (1) | GR81826B (es) |
HU (1) | HU198925B (es) |
IE (1) | IE57306B1 (es) |
LU (1) | LU85254A1 (es) |
NO (1) | NO158136C (es) |
YU (1) | YU45597B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588826A (en) * | 1982-03-29 | 1986-05-13 | Bristol-Myers Company | Ethanediimidamide intermediates |
US4600779A (en) * | 1982-03-29 | 1986-07-15 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
US4578471A (en) * | 1982-03-29 | 1986-03-25 | Bristol-Myers Company | Substituted amino alkyl pyridyl ethanediimidamides |
US4595758A (en) * | 1982-03-29 | 1986-06-17 | Bristol-Myers Company | Ethanediimidamide intermediates |
AU2222083A (en) * | 1982-12-14 | 1984-06-21 | Smith Kline & French Laboratories Limited | Pyridine derivatives |
US4644006A (en) * | 1984-06-22 | 1987-02-17 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
US4692531A (en) * | 1984-06-22 | 1987-09-08 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
CA1275097A (en) * | 1984-10-02 | 1990-10-09 | Fujio Nohara | Pyridyloxy derivatives |
DE3513184A1 (de) * | 1985-04-12 | 1986-10-16 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | 1,3,4-thiadiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US5248673A (en) * | 1992-12-23 | 1993-09-28 | Bristol-Myers Squibb Co. | Bisamidine derivatives as thrombin inhibitors |
US5618816A (en) * | 1995-03-02 | 1997-04-08 | Bristol-Myers Squibb Company | Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines |
TW200517114A (en) | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
ZA200804550B (en) | 2005-11-09 | 2009-08-26 | Combinatorx Inc | Methods, compositions, and kits for the treatment of medical conditions |
US20100092479A1 (en) * | 2008-08-18 | 2010-04-15 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
US20110130711A1 (en) * | 2009-11-19 | 2011-06-02 | Follica, Inc. | Hair growth treatment |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI76795C (fi) * | 1979-09-04 | 1988-12-12 | Bristol Myers Co | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter. |
DE3175201D1 (en) * | 1980-04-30 | 1986-10-02 | Merck & Co Inc | Aminothiadiazoles as gastric secretion inhibitors |
US4394508A (en) * | 1980-06-07 | 1983-07-19 | Bristol-Myers Company | Chemical compounds |
US4380638A (en) * | 1981-03-03 | 1983-04-19 | Bristol-Myers Company | Chemical compounds |
US4380639A (en) * | 1981-03-03 | 1983-04-19 | Bristol-Myers Company | Substituted 1,2,5-thiadiazole derivatives |
-
1983
- 1983-03-16 US US06/475,985 patent/US4440933A/en not_active Expired - Fee Related
-
1984
- 1984-03-12 NO NO840929A patent/NO158136C/no unknown
- 1984-03-13 FI FI841009A patent/FI79848C/fi not_active IP Right Cessation
- 1984-03-14 DK DK155984A patent/DK155984A/da not_active Application Discontinuation
- 1984-03-14 ES ES530590A patent/ES530590A0/es active Granted
- 1984-03-15 IE IE651/84A patent/IE57306B1/en not_active IP Right Cessation
- 1984-03-15 CS CS841859A patent/CS241072B2/cs unknown
- 1984-03-15 CA CA000449644A patent/CA1207763A/en not_active Expired
- 1984-03-15 LU LU85254A patent/LU85254A1/de unknown
- 1984-03-15 HU HU841026A patent/HU198925B/hu not_active IP Right Cessation
- 1984-03-15 GR GR74113A patent/GR81826B/el unknown
- 1984-03-16 KR KR1019840001362A patent/KR860002036B1/ko not_active IP Right Cessation
- 1984-03-16 YU YU46984A patent/YU45597B/sh unknown
- 1984-03-16 DD DD84260980A patent/DD218364A5/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI79848B (fi) | 1989-11-30 |
CA1207763A (en) | 1986-07-15 |
ES8602721A1 (es) | 1985-12-01 |
YU45597B (sh) | 1992-07-20 |
CS185984A2 (en) | 1985-06-13 |
IE840651L (en) | 1984-09-16 |
HU198925B (en) | 1989-12-28 |
IE57306B1 (en) | 1992-07-15 |
FI79848C (fi) | 1990-03-12 |
NO158136C (no) | 1988-07-20 |
NO158136B (no) | 1988-04-11 |
FI841009A (fi) | 1984-09-17 |
YU46984A (en) | 1986-10-31 |
KR860002036B1 (ko) | 1986-11-17 |
CS241072B2 (en) | 1986-03-13 |
DD218364A5 (de) | 1985-02-06 |
LU85254A1 (de) | 1984-11-14 |
KR840008005A (ko) | 1984-12-12 |
NO840929L (no) | 1984-09-17 |
DK155984D0 (da) | 1984-03-14 |
US4440933A (en) | 1984-04-03 |
FI841009A0 (fi) | 1984-03-13 |
DK155984A (da) | 1984-09-17 |
GR81826B (es) | 1984-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES546631A0 (es) | Un procedimiento para la preparacion de derivados de indol | |
ES534825A0 (es) | Un procedimiento para la preparacion de nuevos antagonistas de leucotrieno. | |
ES539625A0 (es) | Un procedimiento para la preparacion de derivados de fenetano. | |
ES540812A0 (es) | Un procedimiento para la preparacion de nuevos derivados delaminometil-oxooxazolidinil-benceno | |
ES533753A0 (es) | Un procedimiento para la preparacion de nuevas fenoxialquil-1-2-4-triazolonas. | |
ES534892A0 (es) | Un procedimiento para la preparacion de derivados de penem-2-metil sustituidos. | |
ES541229A0 (es) | Un procedimiento para la preparacion de nuevos derivados delcromano | |
ES535953A0 (es) | Un procedimiento para la preparacion de derivados 3-cefem-4-carboxilicos. | |
ES530590A0 (es) | Un procedimiento para la preparacion de antagonistas de los receptores h-2 de la histamina. | |
ES530418A0 (es) | Un procedimiento para la preparacion de pirazolopiridinas. | |
ES538907A0 (es) | Un procedimiento para la preparacion de derivados enol-eteres de oxicanis. | |
ES537023A0 (es) | Un procedimiento para la preparacion de nuevos antagonistas de los leucotrienos. | |
ES529462A0 (es) | Un procedimiento para la preparacion de nuevos derivados de benzotiazina | |
ES529846A0 (es) | Un procedimiento para la preparacion de derivados benzoheterociclicos. | |
ES537351A0 (es) | Un procedimiento para la preparacion de compuestos de -lactama | |
ES531338A0 (es) | Un procedimiento para la preparacion de nuevos analogos de la mitomicina. | |
ES533390A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-sulfamoilbenzo (b) tiofeno. | |
ES533389A0 (es) | Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida. | |
ES534642A0 (es) | Un procedimiento para la preparacion de nuevos derivados de carbaciclina. | |
ES529213A0 (es) | Un procedimiento para la preparacion de derivados de isoquinuclidina. | |
ES538335A0 (es) | Un procedimiento para la preparacion de un indol | |
ES534269A0 (es) | Un procedimiento para la preparacion de nuevos derivados de difeniletanona. | |
ES543776A0 (es) | Un procedimiento para la preparacion de nuevos 16-fluor-16, 17-dideshidro prostanoides | |
ES520982A0 (es) | Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina. | |
ES543717A0 (es) | Un procedimiento para la preparacion de derivados de imida- zoben zodiacepina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970519 |